As noted earlier today, Chinese-based prospect Ning Guangyou tested positive for trace amounts of clenbuterol in an out-of-competition drug test administered by USADA, however due to the uniqueness of his test results, he won’t be facing a suspension.
For more information on the unique nature of hie test results and thr banned substance he popped for, read the detailed statement that USADA issued earlier today by clicking here.
While he won’t be facing a suspension as a result of the positive drug test, UFC announced via their official website that his next scheduled fight against Marlon Vera, which was set to go down on the undercard of next Saturday’s UFC 202: Diaz vs. McGregor 2 pay-per-view, has been movved to the UFC Fight Night: Condit vs. Maia event on FOX Sports 1 instead.
Below is the complete statement that the UFC released on Tuesday afternoon:
UFC STATEMEMT ON NING GUANGYOU
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA), the independent administrator of the UFC Anti-Doping Policy, has completed an investigation into the circumstances of a positive test for Ning Guangyou, resulting in a no-fault sanction with no period of ineligibility.
In late July, UFC was made aware of USADA’s investigation into the source of the prohibited substance clenbuterol in an out of competition sample collected from Ning Guangyou. Given it was initially unclear as to the timing of the resolution of the investigation, UFC made the decision to move Guangyou’s scheduled bout against Marlon Vera on August 20, 2016 at UFC 202 to UFC Fight Night: Maia vs. Condit in Vancouver, BC on August 27, 2016.
Details of the USADA investigation into Guangyou’s positive test are available at http://ufc.usada.org/ning-guangyou-receives-finding-no-fault/
As noted earlier today, Chinese-based prospect Ning Guangyou tested positive for trace amounts of clenbuterol in an out-of-competition drug test administered by USADA, however due to the uniqueness of his test results, he won’t be facing a suspension.
For more information on the unique nature of hie test results and thr banned substance he popped for, read the detailed statement that USADA issued earlier today by clicking here<.
While he won’t be facing a suspension as a result of the positive drug test, UFC announced via their official website that his next scheduled fight against Marlon Vera, which was set to go down on the undercard of next Saturday’s UFC 202: Diaz vs. McGregor 2 pay-per-view, has been movved to the UFC Fight Night: Condit vs. Maia event on FOX Sports 1 instead.
Below is the complete statement that the UFC released on Tuesday afternoon:
UFC STATEMEMT ON NING GUANGYOU
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA), the independent administrator of the UFC Anti-Doping Policy, has completed an investigation into the circumstances of a positive test for Ning Guangyou, resulting in a no-fault sanction with no period of ineligibility.
In late July, UFC was made aware of USADA’s investigation into the source of the prohibited substance clenbuterol in an out of competition sample collected from Ning Guangyou. Given it was initially unclear as to the timing of the resolution of the investigation, UFC made the decision to move Guangyou’s scheduled bout against Marlon Vera on August 20, 2016 at UFC 202 to UFC Fight Night: Maia vs. Condit in Vancouver, BC on August 27, 2016.
Details of the USADA investigation into Guangyou’s positive test are available at http://ufc.usada.org/ning-guangyou-receives-finding-no-fault/
As the UFC’s new Anti-Doping Policy gets established in this, its’ first year in existence, there continues to be a lot of “firsts.” This week, another “first” was added to the list.
UFC Bantamweight prospect Ning Guangyou tested positive for trace amounts of clenbuterol in an out-of-competition drug test administered by USADA for a urine sample he provided back on May 19, 2016.
Despite the fact that clenbuterol is listed in the prohibited substances included in UFC’s Anti-Doping Policy, the Chinese fighter won’t be suspended.
USADA issued the following statement on Tuesday, explaining the unique situation:
“USADA announced today that UFC athlete Ning Guangyou, of China, has tested positive for a prohibited substance, which was determined to have been ingested by him without fault or negligence.
Guangyou, 34, tested positive for trace amounts of clenbuterol as the result of an out-of-competition urine sample he provided on May 19, 2016. Clenbuterol is an Anabolic Agent prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List. Consistent with numerous prior reported cases globally, the issue of illicit administration of clenbuterol to animals destined for food production can result in, under specific conditions, a positive sample from an athlete. WADA has issued specific warnings about this problem in China and Mexico. To USADA’s knowledge, due to strict regulatory and meat certification practices, a clenbuterol positive athlete sample has never been reported after consumption of meat produced in the U.S.
USADA reviewed all of the evidence, including the athlete’s whereabouts, dietary habits, and the laboratory reports demonstrating very low parts per billion concentrations of the prohibited substance in the athlete’s urine sample, and concluded that the presence of clenbuterol in the athlete’s sample very likely resulted from clenbuterol contaminated meat consumed in China. As a result, Guangyou will not face a period of ineligibility for his positive test.
While the risk of consuming clenbuterol-tainted meat and testing positive for an athlete is extremely small, consistent with past athlete advisories, USADA reminds athletes to use the utmost care if eating meat in known high risk countries, including Mexico and China. In line with WADA recommendations, USADA will continue to assess the presence of clenbuterol in an athlete’s sample on a case by case basis, taking into account all the evidence supporting the likelihood of such contamination.
As the UFC’s new Anti-Doping Policy gets established in this, its’ first year in existence, there continues to be a lot of “firsts.” This week, another “first” was added to the list.
UFC Bantamweight prospect Ning Guangyou tested positive for trace amounts of clenbuterol in an out-of-competition drug test administered by USADA for a urine sample he provided back on May 19, 2016.
Despite the fact that clenbuterol is listed in the prohibited substances included in UFC’s Anti-Doping Policy, the Chinese fighter won’t be suspended.
USADA issued the following statement on Tuesday, explaining the unique situation:
“USADA announced today that UFC athlete Ning Guangyou, of China, has tested positive for a prohibited substance, which was determined to have been ingested by him without fault or negligence.
Guangyou, 34, tested positive for trace amounts of clenbuterol as the result of an out-of-competition urine sample he provided on May 19, 2016. Clenbuterol is an Anabolic Agent prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List. Consistent with numerous prior reported cases globally, the issue of illicit administration of clenbuterol to animals destined for food production can result in, under specific conditions, a positive sample from an athlete. WADA has issued specific warnings about this problem in China and Mexico. To USADA’s knowledge, due to strict regulatory and meat certification practices, a clenbuterol positive athlete sample has never been reported after consumption of meat produced in the U.S.
USADA reviewed all of the evidence, including the athlete’s whereabouts, dietary habits, and the laboratory reports demonstrating very low parts per billion concentrations of the prohibited substance in the athlete’s urine sample, and concluded that the presence of clenbuterol in the athlete’s sample very likely resulted from clenbuterol contaminated meat consumed in China. As a result, Guangyou will not face a period of ineligibility for his positive test.
While the risk of consuming clenbuterol-tainted meat and testing positive for an athlete is extremely small, consistent with past athlete advisories, USADA reminds athletes to use the utmost care if eating meat in known high risk countries, including Mexico and China. In line with WADA recommendations, USADA will continue to assess the presence of clenbuterol in an athlete’s sample on a case by case basis, taking into account all the evidence supporting the likelihood of such contamination.
